Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

There is a misconception that experiencing constant breathlessness is a typical part of getting older when this is not the ...

Bronchodilators Don't Improve Smoking-Related Respiratory Symptoms in People Without COPD Sep. 5, 2022 — Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Pulmocide Ltd., (“the Company”), a late-stage biopharmaceutical company developing inhaled opelconazole for patients suffering from serious acute and chronic respiratory diseases, today announced that ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges. We ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxtm, today announced ...

Please view our advertising policy and product review methodology for more information. Rather than focusing solely on opening new properties for its core brands, Hyatt has continued to acquire and ...